inducement plan

Absci grants 276,200 non-statutory stock options at $4.92/share to newly hired employee as employment inducement under Nasdaq listing rules.

Zentalis Pharmaceuticals granted 26,000 stock options to new employee at $4.09 exercise price under inducement plan provisions.

Elutia grants 460,000 non-qualified stock options to three new employees at $1.09 exercise price with four-year vesting under Nasdaq inducement rules.

Tango Therapeutics grants new employee 367,500 stock options and 60,000 RSUs valued at $11.94 exercise price under inducement plan.

Iovance granted 3,600 stock options to two new employees at $2.85/share under NASDAQ inducement plan rules, with three-year vesting.